会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Polypeptides having interferon-&ggr; inducing activity
    • 具有干扰素-γ诱导活性的多肽
    • US06476197B1
    • 2002-11-05
    • US08982285
    • 1997-12-01
    • Kozo YamamotoIwao OkamotoMasashi Kurimoto
    • Kozo YamamotoIwao OkamotoMasashi Kurimoto
    • C07K100
    • C07K14/54A61K38/00Y02A50/411
    • Disclosed are created stable polypeptides which are capable of inducing the production of interferon-gamma by immunocompetent cells. The present polypeptides contain specific amino acid sequences usually derived from the wild-type polypeptides, being capable of the production of interferon-gamma, by replacing the cysteine(s) with different amino acid(s). The present polypeptides possess a stability and an activity of inducing the production of IFN-&ggr; by immunocompetent cells, both of which are significantly higher than those of the wild-type polypeptides. In addition to the activity, the present polypeptides can exhibit remarkable activities of inducing the formation of killer cells and enhancing thier cytotoxicities. The present polypeptides are easily obtainable by the process according to the present invention using recombinant DNA techniques. Thus the present polypeptides are useful for agents to treat and/or prevent susceptive diseases such as viral diseases, infections, malignant tumors, and immunopathies.
    • 公开了能够通过免疫活性细胞诱导干扰素-γ产生的稳定多肽。 本发明的多肽含有通常衍生自野生型多肽的能够产生干扰素-γ的特异性氨基酸序列,通过用不同的氨基酸替代半胱氨酸。 本发明的多肽具有通过免疫活性细胞诱导IFN-γ产生的稳定性和活性,两者均明显高于野生型多肽。 除了活性之外,本发明的多肽可以表现出显着的诱导杀伤细胞形成的活性和增强其细胞毒性。 本发明的多肽可以使用重组DNA技术通过本发明的方法容易地获得。 因此,本发明的多肽可用于治疗和/或预防感染性疾病如病毒性疾病,感染,恶性肿瘤和免疫病症的药剂。
    • 2. 发明授权
    • DNA encoding loypeptides having interferon-γ inducing activity
    • 编码具有干扰素-γ诱导活性的寡肽的DNA
    • US07037685B2
    • 2006-05-02
    • US10260576
    • 2002-10-01
    • Kozo YamamotoIwao OkamotoMasashi Kurimoto
    • Kozo YamamotoIwao OkamotoMasashi Kurimoto
    • C12P21/02
    • C07K14/54A61K38/00Y02A50/411
    • Disclosed are created stable polypeptides which are capable of inducing the production of interferon-gamma by immunocompetent cells. The present polypeptides contain specific amino acid sequences usually derived from the wild-type polypeptides, being capable of the production of interferon-gamma, by replacing the cysteine(s) with different amino acid(s). The present polypeptides possess a stability and an activity of inducing the production of IFN-γ by immunocompetent cells, both of which are significantly higher than those of the wild-type polypeptides. In addition to the activity, the present polypeptides can exhibit remarkable activities of inducing the formation of killer cells and enhancing thier cytotoxicities. The present polypeptides are easily obtainable by the process according to the present invention using recombinant DNA techniques. Thus the present polypeptides are useful for agents to treat and/or prevent susceptive diseases such as viral diseases, infections, malignant tumors, and immunopathies.
    • 公开了能够通过免疫活性细胞诱导干扰素-γ产生的稳定多肽。 本发明的多肽含有通常衍生自野生型多肽的能够产生干扰素-γ的特异性氨基酸序列,通过用不同的氨基酸替代半胱氨酸。 本发明的多肽具有通过免疫活性细胞诱导IFN-γ产生的稳定性和活性,两者均明显高于野生型多肽。 除了活性之外,本发明的多肽可以表现出显着的诱导杀伤细胞形成的活性和增强其细胞毒性。 本发明的多肽可以使用重组DNA技术通过本发明的方法容易地获得。 因此,本发明的多肽可用于治疗和/或预防感染性疾病如病毒性疾病,感染,恶性肿瘤和免疫病症的药剂。